A 37-year-old man presented with chronic cavitary pulmonary aspergillosis and hemoptysis
refractory to systemic antifungal therapy with voriconazole and bronchial artery …

Chronic pulmonary aspergillosis (CPA) is a progressive, debilitating clinical condition
associated with significant morbidity. Surgery is the mainstay of treatment for life-threatening …

Background Pulmonary aspergillomas may cause life-threatening hemoptysis. The
treatment of this condition is problematic because poor pulmonary function often precludes …

Pulmonary aspergillosis presents with a variety of clinical forms including invasive
pulmonary aspergillosis, chronic necrotising aspergillosis, aspergilloma, chronic cavitary …

Chronic necrotizing pulmonary aspergillosis is an indolent, locally invasive form of
Aspergillus infection. Treatment options are limited and controversial. Resection is often …

Chronic pulmonary aspergillosis (CPA) is a progressive, debilitating clinical condition
associated with significant morbidity. Surgery is the mainstay of treatment for life-threatening …

Objective: Management of emergency care Background: Hemoptysis due to airway
hemorrhage is treated with hemostatic agents, bronchial artery embolization (BAE), or …

Invasive pulmonary aspergillosis is an opportunistic infection occurring in a background of
severe immune depression. The majority of cases occur in patients who have malignant …

DISCUSSION: Pulmonary aspergilloma is a relatively common cause of recurrent
hemoptysis and cases can range from moderate to severe. Conventional therapies including …

The most common symptom associated with an pulmonary aspergilloma is hemoptysis, with
estimates of frequency ranging from 50 to 85 percent of patients. Hemoptysis may be …